Efficacy of BCG vaccine against leprosy and tuberculosis in northern Malawi
- 1 March 1992
- journal article
- Published by Elsevier BV in The Lancet
- Vol. 339 (8794), 636-639
- https://doi.org/10.1016/0140-6736(92)90794-4
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- BCG, tuberculosis, and leprosyThe Lancet, 1991
- Setting up HIV serology for the Karonga leprosy vaccine trial in MalaŵiLeprosy Review, 1991
- Leprosy and BCG in southern VietnamThe Lancet, 1990
- 2. Background, design and prospects of the Karonga Prevention Trial, a leprosy vaccine trial in northern MalawiTransactions of the Royal Society of Tropical Medicine and Hygiene, 1988
- 1. Sensitivity and specificity of the diagnosis and the search for risk factors for leprosyTransactions of the Royal Society of Tropical Medicine and Hygiene, 1988
- The LEPRA Evaluation Project (LEP), an epidemiological study of leprosy in Northern Malaŵi. I: Methods.Leprosy Review, 1987
- Evaluation of the protective effect of BCG vaccination by a case-control study in Yaounde, CameroonTubercle, 1986
- The protective effect of BCG vaccination of the newborn against childhood tuberculosis in an African communityTubercle, 1986
- PROTECTIVE EFFICACY OF BCG AGAINST LEPROSY IN NORTHERN MALAWIThe Lancet, 1986
- BCG vaccination of children against leprosy in Uganda: final resultsEpidemiology and Infection, 1981